These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
510 related items for PubMed ID: 7821250
21. Localized atrophy with surrounding hair growth in a case of alopecia areata treated with intralesional steroids, using a needle-less injector. Kaliyadan F, Alkhateeb A, Swaroop K. Indian J Dermatol Venereol Leprol; 2018; 84(5):581-582. PubMed ID: 29956680 [No Abstract] [Full Text] [Related]
22. Intralesional betamethasone versus triamcinolone acetonide in the treatment of localized alopecia areata: a within-patient randomized controlled trial. de Sousa VB, Arcanjo FP, Aguiar F, Vasconcelos J, Oliveira AF, Honório A, Pontes J. J Dermatolog Treat; 2022 Mar; 33(2):875-877. PubMed ID: 32594786 [Abstract] [Full Text] [Related]
26. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Abell E, Munro DD. Br J Dermatol; 1973 Jan; 88(1):55-9. PubMed ID: 4686543 [No Abstract] [Full Text] [Related]
27. Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids. Samrao A, Fu JM, Harris ST, Price VH. J Drugs Dermatol; 2013 Feb; 12(2):e36-40. PubMed ID: 23377403 [Abstract] [Full Text] [Related]
29. Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Nakajima T, Inui S, Itami S. Dermatology; 2007 Jul; 215(4):320-4. PubMed ID: 17911990 [Abstract] [Full Text] [Related]
30. Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata: A systematic review and meta-analysis. Yee BE, Tong Y, Goldenberg A, Hata T. J Am Acad Dermatol; 2020 Apr; 82(4):1018-1021. PubMed ID: 31843657 [No Abstract] [Full Text] [Related]
31. Candida antigen immunotherapy versus steroid in the treatment of alopecia areata. Ali S, Ibrahim AM, El Sayed N. Dermatol Ther; 2021 Mar; 34(2):e14802. PubMed ID: 33496068 [Abstract] [Full Text] [Related]
32. Intramuscular triamcinolone acetonide: An undervalued option for refractory alopecia areata. Seo J, Lee YI, Hwang S, Zheng Z, Kim DY. J Dermatol; 2017 Feb; 44(2):173-179. PubMed ID: 27448451 [Abstract] [Full Text] [Related]
33. Long-term intramuscular triamcinolon-acetonide therapy in alopecia areata totalis and universalis. Michalowski R, Kuczyńska L. Arch Dermatol Res; 1978 Feb 15; 261(1):73-6. PubMed ID: 147647 [No Abstract] [Full Text] [Related]
34. Treatment of persistent alopecia areata with sulfasalazine. Rashidi T, Mahd AA. Int J Dermatol; 2008 Aug 15; 47(8):850-2. PubMed ID: 18717871 [Abstract] [Full Text] [Related]
35. Identification of novel step-up regimen of intralesional triamcinolone acetonide in scalp alopecia areata based on a double-blind randomized controlled trial. Rajan M B, Bhardwaj A, Singh S, Budania A, Bains A, Thirunavukkarasu P, Kumar-M P. Dermatol Ther; 2021 Jan 15; 34(1):e14555. PubMed ID: 33210434 [Abstract] [Full Text] [Related]
37. Hyperglycemia following intralesional corticosteroid injection in a patient with type I diabetes mellitus. Fleming P, Drazek L, Shaw JC. J Cutan Med Surg; 2014 Jan 15; 18(4):275-6. PubMed ID: 25008445 [Abstract] [Full Text] [Related]
38. Alopecia areata as a complication of hair restoration surgery. Rodrigues Barata AR, Camacho-Martínez F. Eur J Dermatol; 2012 Jan 15; 22(6):813-4. PubMed ID: 23114187 [No Abstract] [Full Text] [Related]
39. [Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients]. Assouly P, Reygagne P, Jouanique C, Matard B, Marechal E, Reynert P, Bachelez H, Dubertret L. Ann Dermatol Venereol; 2003 Mar 15; 130(3):326-30. PubMed ID: 12746668 [Abstract] [Full Text] [Related]